Biologic therapy is more effective than triple therapy with conventional DMARDs for achieving sustained remission (SR) after an inadequate response to methotrexate monotherapy in patients with rheumatoid arthritis. Patients were also more likely to stay on biologic therapy than triple therapy, according to data from 1,502 patients in the Swedish Rheumatology Quality Register. However the ...
Holy grail of sustained remission ‘elusive’ for some RA patients: experts
By Mardi Chapman
7 Apr 2021